These findings suggested that V.a may be useful in the treatment and prevention of hepatic injury induced by CCl4.

No abstract

No abstract

No abstract

No abstract

No abstract

Ultra-fast one-put microwave assisted strategy is introduced for the synthesis of heterostructured CuCo2S4/CuCo2O4 nanoparticles into a domestic microwave oven with the power of 900 W for 20 min. Thiourea as an organic agent was used as a sulfur source and driving agent to lead the solvent free combustion reaction to obtain this earth-abundant and low-cost mixed chalcogenide/oxide product. The structural and morphological specifications were studied in details using powder x-ray diffraction (XRD), fourier transform infrared spectroscopy (FT-IR), scanning electron microscopy (SEM) and energy dispersion of x-ray spectrometry (EDX). The employed strategy relatively clarifies a new facile, rapid and eco-friendly route to produce heterostructured nanocomposites for different functional purposes.

Background and Aims: Small dense  low-density lipoproteins (sd-LDL) particles are smaller and heavier than typical LDL ones. They can penetrate into the endothelium of coronary arteries more easily because of their small size. Diabetes mellitus is accompanied by dyslipidemia such as increasing concentration of plasma very low density lipoprotein and sd-LDL. Peroxisome proliferator activated receptor γ (PPARγ ) can decrease the level of sd-LDL in plasma. Biochanin A (BCA), a natural compound, is a PPARγ agonist. The present study was designed to investigate the effect of BCA on sd-LDL-Clolesterol level in diabetic animals. Materials and Methods: Adult male rats (Wistar strain) were used as the animal models in this study. Animals were made diabetic by single intraperitoneal injection of Streptozotocin- Nicotinamide and then treated by 1 and 5 mg/kg of BCA for 28 days. Body weight and fasting blood glucose were also tested before and at the end of treatment. Furthermore, the size of LDL particles were measured by nondenaturing polyacrylamide gradient gel electrophoresis assay. Results: Results of the present study indicated that BCA administration at dose of 5mg/kg decreased fasting blood glucose level and increased body weight and diameter of LDL particles in diabetic animals significantly. Conclusions: BCA seems to be an appropriate agent in diabetes mellitus, because it improves the diabetic dyslipidemia, which is the most important complication in diabetic patients.